Sign In
Buy NTLA
$13.02
-0.110 (-0.84%)
At Close: Jun 03, 2026
Sherlock, binx to develop point-of-care Covid-19 test using CRISPR technology
05:54pm, Wednesday, 01'st Jul 2020
The Food and Drug Administration had previously granted an emergency use authorization for Abbott's ID NOW point-of-care test, a decision for which the agency came under fire amid reports of the test
CRISPR Therapeutics Is a Top Pick for Piper Sandler. Here’s Why.
02:50pm, Monday, 29'th Jun 2020
CRISPR Therapeutics announced last Thursday that it would build a new manufacturing facility in Massachusetts to produce its experimental cell therapies....
How Crispr Therapeutics Can Change Everything
12:20pm, Friday, 26'th Jun 2020
But if you want to profit from CRISPR stock, you better get in before the potential pop.
The Incredible Gene-Therapy Breakthroughs to Cure Blindness
08:34am, Friday, 26'th Jun 2020
Some involved the gene-editing technique known as CRISPR. One involves putting a specially engineered gold particle into the retina.
How gene therapy and CRISPR are helping to cure blindness
06:11pm, Thursday, 25'th Jun 2020
The eye is an ideal organ for testing new therapeutic approaches, including CRISPR.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
First sickle cell patient to use CRISPR says technology is working
09:53pm, Tuesday, 23'rd Jun 2020
Mother-of-four Victoria Gray, 34, of Forest, Mississippi, says the controversial gene-editing tool CRISPR has helped alleviate her of severe bouts of pain due to sickle cell disease.
Why CRISPR Therapeutics Stock Just Popped Another 5% | The Motley Fool
08:08pm, Tuesday, 23'rd Jun 2020
Two bullish analyst recommendations in less than 24 hours boost the stock price more than 9%.
CRISPR Stock Is a Worthwhile Investment in Transformative Science
02:50pm, Monday, 22'nd Jun 2020
Experimental genetic treatments could hold the key to a better quality of life for patients and long-term returns for CRISPR stock.
How to buy Regeneron Pharmaceuticals shares from Australia | 17 Jun price $592.9
08:21am, Wednesday, 17'th Jun 2020
Ever wondered how to buy shares in Regeneron Pharmaceuticals in Australia? We explain how and compare the best share trading platforms.
Nature-Inspired CRISPR Enzyme Discoveries Vastly Expand Genome Editing
11:35am, Tuesday, 16'th Jun 2020
Applied computational biology discoveries vastly expand the range of CRISPR’s access to DNA sequences. In nature, bacteria use CRISPR as an adaptive immune system to protect themselves against virus
A Guide to Investing in Gene Editing Stocks
05:59am, Tuesday, 16'th Jun 2020
If we had to pick one disruptive technology that has the most potential to change mankind, it would be synthetic biology (synbio). A critical component of synbio is gene editing. You cannot have one w
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics | The Motley Fool
10:00am, Sunday, 14'th Jun 2020
Each company aims to use its genome editing platform to treat disease, but which has an edge?
Strategic Allocation To Innovation: A Comparison To Emerging Markets
04:22pm, Saturday, 13'th Jun 2020
We believe a strategic allocation to innovation probably will evolve into a sub-asset class. ARK has identified five major innovation platforms and 14 transform
Xconomy: Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More
01:57pm, Friday, 12'th Jun 2020
At the start of 2020 thousands of biotechies anticipated spending the second week of June in San Diego, hobnobbing at the annual conference hosted by the
